title: Lenalidomide monotherapy as salvage treatment for recurrent primary CNS lymphoma.
authors.affiliation: From AP-HP (C.H., S.C., V.T., N.M.-D., S.N., K.M., K.H.-X.), Groupe Hospitalier Pitié-Salpêtrière; "Investissements d'Avenir" ANR-10-IAIHU-06 (C.H., K.M., K.H.-X.), ICM; UPMC University Paris 06, UM 75 (C.H., S.C., V.T., N.M.-D., S.N., K.M., K. H.-X.), ICM, Sorbonne Universités, Paris; Hôpital René Huguenin-Institut Curie (C.S.), Saint Cloud, France; and the LOC French National Network (C.H., S.C., V.T., N.M.-D., S.N., K.M., C.S., K.H.-X.).
authors.forename: Caroline
authors.initials: C
authors.lastname: Houillier
authors.affiliation: From AP-HP (C.H., S.C., V.T., N.M.-D., S.N., K.M., K.H.-X.), Groupe Hospitalier Pitié-Salpêtrière; "Investissements d'Avenir" ANR-10-IAIHU-06 (C.H., K.M., K.H.-X.), ICM; UPMC University Paris 06, UM 75 (C.H., S.C., V.T., N.M.-D., S.N., K.M., K. H.-X.), ICM, Sorbonne Universités, Paris; Hôpital René Huguenin-Institut Curie (C.S.), Saint Cloud, France; and the LOC French National Network (C.H., S.C., V.T., N.M.-D., S.N., K.M., C.S., K.H.-X.).
authors.forename: Sylvain
authors.initials: S
authors.lastname: Choquet
authors.affiliation: From AP-HP (C.H., S.C., V.T., N.M.-D., S.N., K.M., K.H.-X.), Groupe Hospitalier Pitié-Salpêtrière; "Investissements d'Avenir" ANR-10-IAIHU-06 (C.H., K.M., K.H.-X.), ICM; UPMC University Paris 06, UM 75 (C.H., S.C., V.T., N.M.-D., S.N., K.M., K. H.-X.), ICM, Sorbonne Universités, Paris; Hôpital René Huguenin-Institut Curie (C.S.), Saint Cloud, France; and the LOC French National Network (C.H., S.C., V.T., N.M.-D., S.N., K.M., C.S., K.H.-X.).
authors.forename: Valerie
authors.initials: V
authors.lastname: Touitou
authors.affiliation: From AP-HP (C.H., S.C., V.T., N.M.-D., S.N., K.M., K.H.-X.), Groupe Hospitalier Pitié-Salpêtrière; "Investissements d'Avenir" ANR-10-IAIHU-06 (C.H., K.M., K.H.-X.), ICM; UPMC University Paris 06, UM 75 (C.H., S.C., V.T., N.M.-D., S.N., K.M., K. H.-X.), ICM, Sorbonne Universités, Paris; Hôpital René Huguenin-Institut Curie (C.S.), Saint Cloud, France; and the LOC French National Network (C.H., S.C., V.T., N.M.-D., S.N., K.M., C.S., K.H.-X.).
authors.forename: Nadine
authors.initials: N
authors.lastname: Martin-Duverneuil
authors.affiliation: From AP-HP (C.H., S.C., V.T., N.M.-D., S.N., K.M., K.H.-X.), Groupe Hospitalier Pitié-Salpêtrière; "Investissements d'Avenir" ANR-10-IAIHU-06 (C.H., K.M., K.H.-X.), ICM; UPMC University Paris 06, UM 75 (C.H., S.C., V.T., N.M.-D., S.N., K.M., K. H.-X.), ICM, Sorbonne Universités, Paris; Hôpital René Huguenin-Institut Curie (C.S.), Saint Cloud, France; and the LOC French National Network (C.H., S.C., V.T., N.M.-D., S.N., K.M., C.S., K.H.-X.).
authors.forename: Soledad
authors.initials: S
authors.lastname: Navarro
authors.affiliation: From AP-HP (C.H., S.C., V.T., N.M.-D., S.N., K.M., K.H.-X.), Groupe Hospitalier Pitié-Salpêtrière; "Investissements d'Avenir" ANR-10-IAIHU-06 (C.H., K.M., K.H.-X.), ICM; UPMC University Paris 06, UM 75 (C.H., S.C., V.T., N.M.-D., S.N., K.M., K. H.-X.), ICM, Sorbonne Universités, Paris; Hôpital René Huguenin-Institut Curie (C.S.), Saint Cloud, France; and the LOC French National Network (C.H., S.C., V.T., N.M.-D., S.N., K.M., C.S., K.H.-X.).
authors.forename: Karima
authors.initials: K
authors.lastname: Mokhtari
authors.affiliation: From AP-HP (C.H., S.C., V.T., N.M.-D., S.N., K.M., K.H.-X.), Groupe Hospitalier Pitié-Salpêtrière; "Investissements d'Avenir" ANR-10-IAIHU-06 (C.H., K.M., K.H.-X.), ICM; UPMC University Paris 06, UM 75 (C.H., S.C., V.T., N.M.-D., S.N., K.M., K. H.-X.), ICM, Sorbonne Universités, Paris; Hôpital René Huguenin-Institut Curie (C.S.), Saint Cloud, France; and the LOC French National Network (C.H., S.C., V.T., N.M.-D., S.N., K.M., C.S., K.H.-X.).
authors.forename: Carole
authors.initials: C
authors.lastname: Soussain
authors.affiliation: From AP-HP (C.H., S.C., V.T., N.M.-D., S.N., K.M., K.H.-X.), Groupe Hospitalier Pitié-Salpêtrière; "Investissements d'Avenir" ANR-10-IAIHU-06 (C.H., K.M., K.H.-X.), ICM; UPMC University Paris 06, UM 75 (C.H., S.C., V.T., N.M.-D., S.N., K.M., K. H.-X.), ICM, Sorbonne Universités, Paris; Hôpital René Huguenin-Institut Curie (C.S.), Saint Cloud, France; and the LOC French National Network (C.H., S.C., V.T., N.M.-D., S.N., K.M., C.S., K.H.-X.). khe.hoang-xuan@psl.aphp.fr.
authors.forename: Khê
authors.initials: K
authors.lastname: Hoang-Xuan
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D016543:Central Nervous System Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D012189:Retrospective Studies; D016879:Salvage Therapy; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D020533:Angiogenesis Inhibitors; D013792:Thalidomide; D000077269:Lenalidomide